Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus gasseri BNR17 and Reduced Body Weight

Research synthesisLow evidenceSmall effect3 studies · 1 beneficial · 2 neutral · 0 harmful

Across 3 studies of Lactobacillus gasseri BNR17 for reduced body weight, 1 reported a small beneficial effect (a meta-analysis showing a significant reduction of 1.16 kg), while 2 randomized controlled trials found no statistically significant difference between groups. The predominant effect size was small, and the overall evidence suggests a modest, inconsistent effect on body weight, typically observed in obese adults.

  • Studied populations: obese adults without comorbidities, obese adults aged 19–75 years

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. Many of the included studies did not reach statistical significance — effect may be smaller than the predominant direction suggests. Dosing was inconsistently reported, and study durations were not available for most trials, limiting the ability to determine optimal usage duration.

Generated May 12, 2026
Doses used in studies
  • CFU/day: 10 billion (median 10 billion, IQR 10 billion10 billion) 1 study
Safety in these studies
4 of 4 papers
Back to top